FREE Study: investigating the effectiveness of EMDR as a treatment for Fear of Cancer Recurrence among cancer survivors.
- Conditions
- survivors of mamacarcinoma and coloncarcinoma with high levels of fear of cancer recurrence (FCR)
- Registration Number
- NL-OMON26554
- Lead Sponsor
- MC Leids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 10
In order to be eligible to participate in this study, a subject must meet all of the following criteria: Adult (18 - 70 years) survivors of breast cancer (female) or colon cancer (male/female) after ending treatment. Participants must be able to rapport on a daily basis on an online questionnaire, so minimal computer skills are necessary. Participants with a low to normal score will not participate in the treatment phase of the study. Participants with a score above 13 (cut of score) on the CWS will be included for the treatment phase of the study. A signed informed consent is necessary to participate.
A potential subject who meets any of the following criteria will be excluded from participation in this study: Age under 18 years or over 70 years, obvious intellectual impairment, and insufficient knowledge of the Dutch language. Patients with acute psychiatric problems such as acute psychotic disorders or suicidality will be excluded. Patients using medication that has an effect on anxiety need to be on stable medication for at least three months and keep medication unchanged during the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure (DQ-FCR) is an online list of 5 questions based on the FCRI-NL severity scale, adapted for daily measurement, which are answered daily during 16 weeks (14 weeks of the study and 2 weeks follow-up).
- Secondary Outcome Measures
Name Time Method the effect of EMDR on the total scores of the CWS, FCRI-NL and item 30 about quality of life of the EORTC-QLQ-C30, and DQ-PNF will be investigated. Marital status, stage of disease, treatment variables, age, gender, educational level will be investigated as descriptive variables